BioSpace · 2 days ago
Safety Statistician, Senior Manager
Wonder how qualified you are to the job?
BiotechnologyCommunities
Insider Connection @BioSpace
Responsibilities
Provide statistical expertise to Centralized Statistical Monitoring and Quality Tolerance Limit projects
Plan and execute statistical contributions to protocols, Flash Memos, and Clinical Study Reports (CSRs).
Provide statistical inputs to clinical publications, Clinical Summary of Safety (CSSs), Clinical Summary of Efficacy (CSEs), Clinical Overviews (COs), and regulatory documents.
Oversee statistical work performed by study statisticians.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Doctorate degree and 2 years of experience OR
Masters degree and 4 years of experience OR
Bachelors degree and 6 years of experience OR
Associates degree and 10 years of experience OR
High school diploma / GED and 12 years of experience
Preferred
Technically strong with hands-on experience of various design and statistical analysis
Clinical trial experience
Any safety assessment experience and/or experience of application of Bayesian methodology in a clinical trials environment is a plus
Experience working effectively in a globally dispersed team environment with cross-cultural partners
Proficiency in developing or supervising the development of data visualization tools and data analysis applications using e.g. R/Shiny is highly desirable
Benefits
Comprehensive employee benefits package
Retirement and Savings Plan
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
Discretionary annual bonus program
Stock-based long-term incentives
Award-winning time-off plans
Bi-annual company-wide shutdowns
Flexible work models, including remote work arrangements
Company
BioSpace
BioSpace is the leading online community for industry news and careers for life science professionals.
Funding
Current Stage
Growth StageTotal Funding
$10M2000-08-24Series B· $10M
Recent News
2024-05-31
2024-05-05
2024-04-06
Company data provided by crunchbase